Comparing GLP-1 medications and supplement needs Not all GLP-1 medications create identical nutritional challenges, and your specific medication may influence which supplements matter most

References: Prescription Fills for Semaglutide Products by Payment Method | Health Policy | JAMA Health Forum | JAMA Network Amylin brain circuitry ScienceDirect Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats ScienceDirect Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity | Diabetes Care | American Diabetes Association Eli Lillys experimental obesity drug shows over 11% weight loss in early trial | Reuters Chronic Weight Management Trial Results | Wegovy (semaglutide) Novo Nordisk presents phase 3 data for next-generation CagrilintideSemaglutide in Adults with Overweight or Obesity and Type 2 Diabetes | New England Journal of Medicine Roche to present new pivotal data at ASH 2021 from broad and comprehensive portfolio, challenging treatment standards for people with blood disorders Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio | Pfizer AstraZeneca Targets Obesity Market with Potential $2B Deal for Early GLP-1 Candidate BioSpace Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron | Pfizer

These risk reductions for heart and kidney disease outcomes are comparable to what weve seen for type 2 diabetes patients taking GLP-1-RA drugs, and its reassuring that we saw no sign of any new safety issues, says study senior author Jung-Im Shin, MD, PhD, an associate professor in the Bloomberg Schools Department of Epidemiology
How might GLP-1s affect birth control pills
IF is praised for benefits like improved insulin sensitivity, fat loss, and metabolic health
Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes